MassChallenge

Neurava is a company focused on developing non-invasive wearable diagnostic devices for patients with epilepsy, particularly those at risk of Sudden Unexpected Death in Epilepsy (SUDEP). The company's innovative device monitors critical biological signals related to epilepsy, providing timely alerts to caregivers and patients. By offering a reliable monitoring solution, Neurava aims to enhance patient autonomy and deliver peace of mind to families, facilitating timely intervention when necessary. The company's work lies at the intersection of medical device manufacturing and health diagnostics, addressing a significant need within the epilepsy patient community.

NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

ValueMyBrain is a smart safety helmet to prevent accidents for helmet-wearing workers (construction, oil & gas, building maintenance etc.). Value My Brain captures EEG raw data, processes them in real time in the cloud, and identifies loss of attention leading to risky conditions. Workers (and/or their organization) at risk are alerted, allowing a reduction in accidents. Our product is based on a proprietary algorithm that we are bringing from clinical to industrial level. We are developing ValueMyBrain in close cooperation with some universities and with a San Jose based leading manufacturer of physiological sensors technology.

Neuroelectrics is a digital brain health company founded in 2012 and headquartered in Barcelona, Catalonia. It specializes in the development of non-invasive, high-definition electrical brain stimulation technology, including wireless EEG and various stimulation devices such as tDCS, tACS, and tRNS, which feature up to 32 channels. The company's products aim to monitor and enhance brain health by measuring and modifying brain function, thereby enabling healthcare professionals to restore brain health, reduce disabilities, and improve the quality of life for patients. In addition to its hardware offerings, Neuroelectrics also provides software and research services that support personalized neuromodulation.